Botox News and Research

RSS

Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum. It's the same toxin that causes a life-threatening type of food poisoning called botulism. Doctors use it in small doses to treat health problems, including, temporary removal of facial wrinkles, severe underarm sweating, cervical dystonia - a neurological disorder that causes severe neck and shoulder muscle contractions, blepharospasm - uncontrollable blinking, strabismus - misaligned eyes. Botox injections work by weakening or paralyzing certain muscles or by blocking certain nerves. The effects last about three to four months. Side effects can include pain at the injection site, flu-like symptoms, headache and upset stomach. Injections in the face may also cause temporary drooping eyelids. You should not use Botox if you are pregnant or breast feeding.

Allergan agrees to acquire KYTHERA Biopharmaceuticals for $2.1 billion

Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.

17 Jun 2015

3-D imaging technique may be useful for measuring efficacy of injectable wrinkle reducers

A three-dimensional imaging technique often used in the automotive and aerospace industries for accurate measurement may be useful to measure the efficacy of injectable wrinkle reducers such as Botox and Dysport, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

28 May 2015

Botulinum toxin A effective for treating bladder disorders

While Botulinum toxin A (BTX-A), known to the public as Botox, is commonly associated with smoothing wrinkles for a more youthful appearance, three studies presented at the 110th Annual Scientific Meeting of the American Urological Association are proving BTX-A to be more than just a cosmetic solution.

17 May 2015

Study finds botulinum toxin injections in epicardial fat pads reduce AF risk immediately following surgery and after one year of follow-up

AF is the most common arrhythmia complicating cardiac surgery and occurs in approximately 30-40 percent of patients undergoing CABG surgery...

15 May 2015

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Researchers from Montefiore Health System and Albert Einstein College of Medicine will present new findings on how to effectively treat migraine, and forecast the onset of pain in a number of neurological conditions including dementia in older adults.

21 Apr 2015

Toxic Botox travels through our nerves to reach central nervous system

New research might bring a frown to even the most heavily botoxed faces, with scientists finding how some of the potent toxin used for cosmetic surgery escapes into the central nervous system.

17 Apr 2015

Intronix Technologies, Western University collaborate to develop rehabilitation devices

Intronix Technologies will be collaborating with Western University's Department of Electrical and Computer Engineering to develop technology to be incorporated into rehabilitation devices.

16 Dec 2014

Dermatology expert to deliver presentation at 2015 ODAC

A leader in the specialty of cosmetic dermatology, Dr. Leslie Baumann of Miami, Florida will be a featured speaker at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC) in Orlando January 16-19, 2015.

1 Dec 2014

Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

A multidisciplinary team of experts affiliated with the Cedars-Sinai Movement Disorders Program will present a free conference for patients, families and caregivers on treatment options for dystonia, which causes painful and potentially crippling muscle contractions.

30 Sep 2014

Anti-addiction activists press for FDA chief to step down

More than a dozen organizations are asking that Dr. Margaret Hamburg, who has headed the Food and Drug Administration since 2009, be replaced because under her leadership they say the agency's policies have contributed to prescription painkiller abuse.

25 Sep 2014

Blocking nerve signals could be effective treatment for stomach cancer

Research from Columbia University Medical Center shows that nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox® (onabotulinumtoxinA) could be an effective treatment for the disease.

21 Aug 2014

Study confirms benefit of surgical treatment for migraines

Dr. Oren Tessler, Assistant Professor of Clinical Surgery at LSU Health Sciences Center New Orleans School of Medicine, is part of a team of plastic and reconstructive surgeons who report a high success rate using a method to screen and select patients for a specific surgical migraine treatment technique.

1 Aug 2014

Plastic surgeons consider themselves the most capable injectors, shows study

According to a study led by American scientists, plastic surgeons consider themselves the most capable injectors.

31 Jul 2014

Non-endoscopic procedure effective in treating severe chronic migraine headaches

A revised version of a surgical procedure to treat severe chronic migraine headaches led to significant symptom relief more than 90 percent of the time in patients treated at Massachusetts General Hospital.

29 Jul 2014

VMGI enters into MOU with Power Shark Capital for distribution of beauty and cosmetic products

Verde Media Group Inc. (OTC: VMGI) is pleased to announce that it has recently entered into a Memorandum of Understanding, through its subsidiary Beautyject Inc., with Power Shark Capital ("PSC") for the sale and distribution of its beauty and cosmetic products throughout North America.

31 May 2014

Study on effect of Botox on depression

In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.

2 Apr 2014

Beverly Hills Physicians receives ALLERGAN PARTNER PRIVILEGES Top 50 award

Throughout Southern California, Beverly Hills Physicians has long been the ideal option for cosmetic procedures like breast augmentation. With BHP's various facilities throughout the region (each approved by the American Association for Accreditation of Ambulatory Surgery, Inc.), their plastic surgery patients always know they're receiving the safest and most effective surgery.

13 Mar 2014

Study: Rise of 'selfies' have huge impact on facial plastic surgery industry

The rise of 'selfies' is having a huge impact on the facial plastic surgery industry according to a new study by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll studies a select group of the organization's 2,700 members to uncover the latest trends in facial plastic surgery.

11 Mar 2014

GLNT study to evaluate abnormal muscle tone caused by neurological disorders

Great Lakes NeuroTechnologies announced today that it is launching a study to determine the feasibility of a clinician-worn glove to objectively evaluate abnormal muscle tone, such as stiff joints or muscle tightness, due to neurological disorders.

16 Jan 2014

Researchers review effectiveness of Botox injections for overactive bladder symptoms

AN INNOVATIVE treatment helping patients with overactive bladder symptoms lead normal lives again has been licensed for use by the UK’s medicines watchdog following a landmark study in which Sheffield Teaching Hospitals NHS Foundation Trust played a leading role.

6 Nov 2013